Debating Genomic Medicine | GenomeWeb

If whole-genome sequencing ever becomes a common part of treating patients, as is expected by many, some tricky ethical and privacy-related problems may arise, most notably questions about what should be done about incidental findings and malevolent things doctors find in the genome that have no treatment.

At Washington University in St. Louis this week, at a global center of genomic medicine, a few experts met in a panel discussion to sift around a bit through the morass of ethical questions whole-genome sequencing might stir up when it does hit the clinic.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Big Three

Just Another Test

Peace of Mind

A Genetic Sneak Peek

Born Sick

A researcher argues that big prizes like the Nobel or Lasker awards send the wrong message about research.

Maria Freire, the president of the Foundation for the National Institutes of Health, discusses recent genomics-fueled advances with The Open Mind's Alexander Heffner.

Three researchers win the Nobel Prize for their efforts to develop treatments for parasitic diseases.

In PLOS this week: effect of variants linked to body shape differs by age and sex, transcriptome differences in bats with and without white-nose syndrome, and more.